SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma.
fibronectin 1
hub genes
microarray technology
secreted phosphoprotein 1
tongue squamous cell carcinoma
Journal
Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
13
11
2019
accepted:
18
09
2020
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
ppublish
Résumé
Tongue squamous cell carcinoma (TSCC) is one of the most common malignant tumor types in the oral and maxillofacial region. The etiology and pathogenesis behind TSCC is complicated. In the present study, three gene expression profiles, namely GSE31056, GSE13601 and GSE78060, were downloaded from the Gene Expression Omnibus (GEO). The GEO2R online tool was utilized to identify differentially expressed genes (DEGs) between TSCC and normal tissue samples. Furthermore, a protein-protein interaction (PPI) network was constructed and hub genes were validated and analyzed. A total of 83 common DEGs were obtained in three datasets, including 48 upregulated and 35 downregulated genes. Pathway enrichment analysis indicated that DEGs were primarily enriched in cell adhesion, extracellular matrix (ECM) organization, and proteolysis. A total of 63 nodes and 218 edges were included in the PPI network. The top 11 candidate hub genes were acquired, namely plasminogen activator urokinase (PLAU), signal transducer and activator of transcription 1, C-X-C motif chemokine ligand 12, matrix metallopeptidase (MMP) 13, secreted phosphoprotein 1 (SPP1), periostin, MMP1, MMP3, fibronectin 1 (FN1), serpin family E member 1 and snail family transcriptional repressor 2. Overall, 83 DEGs and 11 hub genes were screened from TSCC and normal individuals using bioinformatics and microarray technology. These genes may be used as diagnostic and therapeutic biomarkers for TSCC. In addition, SPP1 and FNl were identified as potential biomarkers for the progression of TSCC.
Identifiants
pubmed: 34457068
doi: 10.3892/ol.2021.12974
pii: OL-0-0-12974
pmc: PMC8358624
doi:
Types de publication
Journal Article
Langues
eng
Pagination
713Informations de copyright
Copyright: © Xu et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
J Surg Oncol. 2018 Apr;117(5):1092-1099
pubmed: 29432642
Exp Ther Med. 2019 May;17(5):4089-4099
pubmed: 31007745
Oncol Lett. 2019 Feb;17(2):2377-2387
pubmed: 30675303
Clin Exp Metastasis. 2015 Oct;32(7):739-53
pubmed: 26319373
Cell Prolif. 2016 Oct;49(5):628-35
pubmed: 27571935
Med Sci Monit. 2017 Dec 14;23:5924-5932
pubmed: 29240723
Cancer Res Treat. 2017 Jul;49(3):695-705
pubmed: 27737535
Biomarkers. 2013 Feb;18(1):63-72
pubmed: 23116545
Aging (Albany NY). 2017 Jun 12;9(6):1477-1536
pubmed: 28611316
J Comput Biol. 2020 Jan;27(1):55-68
pubmed: 31424286
Arch Oral Biol. 2020 Feb;110:104587
pubmed: 31734541
Acta Otorhinolaryngol Ital. 2018 Jun;38(3):175-180
pubmed: 29984792
Eur Respir J. 2019 Aug 22;54(2):
pubmed: 31221805
Cancers (Basel). 2019 Apr 30;11(5):
pubmed: 31052345
Semin Cancer Biol. 2018 Oct;52(Pt 2):228-240
pubmed: 29355614
Cancer Res. 2017 Jan 15;77(2):532-544
pubmed: 27821487
Head Neck. 2017 Feb;39(2):297-304
pubmed: 27696557
Dis Markers. 2012;32(1):51-64
pubmed: 22297602
Int J Cancer. 2013 Aug 1;133(3):568-78
pubmed: 23364881
Oncol Lett. 2018 Jul;16(1):543-551
pubmed: 29928443
J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):1033-1038
pubmed: 30043590
Oncol Lett. 2019 Jun;17(6):5681-5685
pubmed: 31186792
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6032-9
pubmed: 25337248
J Cell Sci. 2002 Oct 15;115(Pt 20):3861-3
pubmed: 12244123
ORL J Otorhinolaryngol Relat Spec. 2014;76(5):273-81
pubmed: 25471249
Hum Mol Genet. 2019 Oct 15;28(20):3431-3442
pubmed: 31411676
Cornea. 2013 Nov;32(11):1465-9
pubmed: 24055903
J Am Acad Dermatol. 1985 Mar;12(3):515-21
pubmed: 3989010
Exp Cell Res. 2017 Oct 15;359(2):449-457
pubmed: 28830685
Med Mol Morphol. 2018 Jun;51(2):102-110
pubmed: 29280012
Mol Cancer Ther. 2019 Aug;18(8):1430-1438
pubmed: 31171582
Br J Cancer. 2018 Sep;119(6):724-736
pubmed: 30131545
Oncol Rep. 2017 Feb;37(2):737-746
pubmed: 28075446
J Surg Oncol. 2018 Jun;117(8):1833-1840
pubmed: 29761507
Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3317-25
pubmed: 12882776
Mol Carcinog. 2013 Mar;52(3):229-36
pubmed: 22161744
Oral Oncol. 1998 Jul;34(4):284-91
pubmed: 9813724
Biomed Pharmacother. 2017 Jul;91:1167-1177
pubmed: 28531945
Aging (Albany NY). 2018 May 18;10(5):1000-1014
pubmed: 29779016
Int J Mol Med. 2018 Sep;42(3):1418-1426
pubmed: 29956740
J Oral Pathol Med. 2011 Feb;40(2):127-34
pubmed: 20969624
Oral Oncol. 2019 Feb;89:14-22
pubmed: 30732952
Oncotarget. 2016 Nov 8;7(45):72758-72766
pubmed: 27602581
J Comput Biol. 2019 Dec;26(12):1379-1393
pubmed: 31290683
Acta Pharmacol Sin. 2013 Jan;34(1):176-84
pubmed: 23103626
Gene. 2018 Dec 30;679:398-404
pubmed: 30240883
Mol Med Rep. 2019 Apr;19(4):2599-2610
pubmed: 30816460
Open Access Maced J Med Sci. 2018 Jan 13;6(1):134-136
pubmed: 29484010
Clin Cancer Res. 2018 Mar 1;24(5):1163-1175
pubmed: 29246940
Aging (Albany NY). 2019 Sep 5;11(17):6960-6982
pubmed: 31487691
Viruses. 2015 Mar 20;7(3):1332-43
pubmed: 25803099
J Exp Clin Cancer Res. 2019 Sep 3;38(1):386
pubmed: 31481087
Int J Pharm. 2019 Jan 10;554:93-104
pubmed: 30385376
Clin Cancer Res. 2006 Feb 15;12(4):1308-16
pubmed: 16489088
J Cell Biochem. 2018 Jun;119(6):4717-4728
pubmed: 29274284
Matrix Biol. 2014 Jul;37:131-41
pubmed: 24657887
Mod Pathol. 2019 Dec;32(12):1762-1771
pubmed: 31273315
Cancer Med. 2020 Nov;9(22):8333-8344
pubmed: 33047888
Gene X. 2020 Mar 14;5:100031
pubmed: 32550557
Spine (Phila Pa 1976). 2005 Apr 1;30(7):722-8
pubmed: 15803072
Oncologist. 2018 Dec;23(12):1415-1425
pubmed: 29739896
Oral Oncol. 2010 Sep;46(9):636-43
pubmed: 20637679
Onco Targets Ther. 2020 Nov 17;13:11855-11867
pubmed: 33239888
Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Sep;43(5):683-6
pubmed: 23230738
Int J Clin Exp Med. 2015 Nov 15;8(11):20911-7
pubmed: 26885018
Blood. 1995 Nov 1;86(9):3452-60
pubmed: 7579450
Head Neck. 2015 Nov;37(11):1642-9
pubmed: 24954188
Oncol Rep. 2019 Sep;42(3):911-922
pubmed: 31322245
Oncol Lett. 2016 Feb;11(2):1021-1025
pubmed: 26893685
Cell Mol Biol Lett. 2018 Nov 15;23:53
pubmed: 30459815
Clin Biochem. 2019 May;67:24-32
pubmed: 30825424
J Cancer Res Ther. 2011 Apr-Jun;7(2):138-42
pubmed: 21768699
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Nov;43(11):826-9
pubmed: 19267973
Surgeon. 2019 Feb;17(1):6-14
pubmed: 29843958